Reflections on the Innovative Medicines Initiative

被引：0
|
作者：
Michel Goldman
机构：
[1] Michel Goldman is Executive Director of the Innovative Medicines Initiative,
[2] B-1060 Brussels,undefined
[3] Belgium.,undefined
来源：
Nature Reviews Drug Discovery | 2011年 / 10卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The pharmaceutical industry is developing new collaborative models for drug development. This article discusses the experience so far of the Innovative Medicines Initiative, which is currently the largest public–private partnership that is dedicated to pharmaceutical innovation, highlighting lessons learned for the success of precompetitive consortia.
引用
收藏
页码：321 / 322
页数：1
相关论文
共 50 条
  • [31] INNOVATIVE MEDICINES INITIATIVE IN THE ANDALUSIAN REGION. ON THE FRONTIER OF ADVANCED CLINICAL PHARMACOLOGY
    Lucena, M. I.
    Hernandez, C.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109 : 15 - 15
  • [32] The Innovative Medicines Initiative launches call on Ebola and other filoviral haemorrhagic fevers
    EUROSURVEILLANCE, 2014, 19 (45): : 43 - 43
  • [33] The Innovative Medicines Initiative-10 Years of Public-Private Collaboration
    Laverty, Hugh
    Meulien, Pierre
    FRONTIERS IN MEDICINE, 2019, 6
  • [34] THE INNOVATIVE MEDICINES INITIATIVE: A PUBLIC PRIVATE PARTNERSHIP MODEL TO FOSTER DRUG DISCOVERY
    Vaudano, Elisabetta
    COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL, 2013, 6 (07): : e201303017
  • [35] Editorial: The Innovative Medicines Initiative - collaborations are key to innovating R&D processes
    1600, Wiley-VCH Verlag (09):
  • [36] The governance structure for data access in the DIRECT consortium: an innovative medicines initiative (IMI) project
    Teare, Harriet J. A.
    de Masi, Federico
    Banasik, Karina
    Barnett, Anna
    Herrgard, Sanna
    Jablonka, Bernd
    Postma, Jacqueline W. M.
    McDonald, Timothy J.
    Forgie, Ian
    Chmura, Piotr J.
    Rydzka, Emil K.
    Gupta, Ramneek
    Brunak, Soren
    Pearson, Ewan
    Kaye, Jane
    LIFE SCIENCES SOCIETY AND POLICY, 2018, 14
  • [37] Editorial: The Innovative Medicines Initiative - collaborations are key to innovating R&D processes
    Laverty, Hugh
    Goldman, Michel
    BIOTECHNOLOGY JOURNAL, 2014, 9 (09) : 1095 - 1096
  • [38] Medicines for all initiative
    Gupton, Frank
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 252
  • [39] The innovative medicines initiative IMI-A new collaborative approach to drug safety testing and beyond
    Gottwald, Matthias
    TOXICOLOGY LETTERS, 2009, 189 : S265 - S265
  • [40] DILI revisited - key results from the innovative medicines initiative MIP-DILI project
    Hewitt, P.
    Weaver, R. J.
    TOXICOLOGY LETTERS, 2019, 314 : S43 - S43
12345